Abstract:Abstract Introduction Untargeted metabolomics, an analysis of the molecular layer comprising many smaller molecular weight biomolecules, has emerged as a tool to diagnose and predict outcomes early in disease courses. Existing studies of metabolic changes following burn injury focus on select targeted metabolites using animal models. This study aims to identify metabolic signatures associated with burn severity and clinical outcomes using untargeted metabolomics analysis in patients. Methods Burn patients admitted to a regional center over the span of 4 years were prospectively enrolled in this study. Patient demographics, burn injury characteristics, and blood samples were collected at set timepoints from admission until 4 weeks. Mass spectrometry (MS)-based method was used to measure untargeted metabolomics. Comparison of the MS-based measurements of select metabolites with alternate standard clinical assaying was performed to ensure concordance and reliability. A linear regression model was then used to identify metabolites associated with bun severity (TBSA < 20% and ≥ 20%). Age, gender, BMI, presence of inhalation injury, administration of propofol and supplemental nutrition were added as covariates to control for confounding effects. Results Complete metabolome datasets were collected for 58 patients from a total of 115 patients reviewed. The sample had a median TBSA of 18.3%, median age of 38.5 and 27.6% had concomitant inhalation injury. A total of 925 metabolites, including 335 lipids, 183 amino acids, 146 xenobiotics, 24 carbohydrates, and 23 peptides were analyzed. MS-based measurements compared with alternate standard clinical assaying resulted in a high level of concordance (R ~ 0.8). The first two principal components (account for 22% of total variance) show the main drivers of global metabolomics variation are time since admission and severity of injury. At admission, a significant elevation of xenobiotics, amino acids, nucleotide, and lipids related metabolites was observed among severely burned patients (TBSA ≥ 20%). Longitudinal analysis reveal that xenobiotic related metabolites are significantly elevated at admission but are depleted overtime. An abundance of select metabolites at admission showed an excellent ability to predict 30-day mortality (AUROC ~ 90%). Conclusions Patterns of metabolic alterations were associated with severe burn injury (TBSA ≥ 20%). Distinct classes of metabolic profiles change in a time dependent manner. Therefore, metabolic profiling has the potential to be used as early indicators of disease severity and progression. Applicability of Research to Practice Identifying and utilizing early indicators of disease severity and outcomes before the onset of clinical signs is crucial for burn patients. Metabolomic changes is a prime candidate for the development of these prognostic and biomarker panels.

12 Monitoring Monocyte Anisocytosis Changes as a Burn Injury Recovery Marker: Insights from a Clinical Study

Monocyte Anisocytosis Changes in Patients after Major Burn Injuries

The Monocyte-to-Lymphocyte Ratio on the 6th Day Postburn Is Associated with Clinical Outcome of Severe Burns.

The Asynchronous Dynamic Changes and Interrelationships Between Leukocyte Composition and Inflammatory Markers and Potential Clinical Significance in the Early Stage and Sepsis Stage in Severe Burns.

The asynchronous dynamic changes and interrelationships between leukocyte compositions and inflammatory markers and potential clinical significance in the early stage and sepsis stage in severe burns

Burn Injury Induces Proinflammatory Plasma Extracellular Vesicles That Associate with Length of Hospital Stay in Women: CRP and SAA1 as Potential Prognostic Indicators

Investigation and assessment of neutrophil dysfunction early after severe burn injury

Burn-injured skin is marked by a prolonged local acute inflammatory response of innate immune cells and pro-inflammatory cytokines

21 Untargeted Metabolomics Analysis: A Candidate Biomarker and Prognostic Tool in Burn Injury

18 High Mobility Group Box-1 Is Not Correlated with the Persistent Hyperinflammatory Response After Burn Injury

Persistent Systemic Inflammation in Patients With Severe Burn Injury Is Accompanied by Influx of Immature Neutrophils and Shifts in T Cell Subsets and Cytokine Profiles

Increased oxidative phosphorylation in lymphocytes does not atone for decreased cell numbers after burn injury

[The Significance of Changes in Serum Soluble Lipopolysaccharide Receptor CD14 Levels in Burned Patients with Multiple Organ Dysfunction Syndrome].

Nonsevere Burn Induces a Prolonged Systemic Metabolic Phenotype Indicative of a Persistent Inflammatory Response Postinjury

The systemic inflammation indexes after admission predict in-hospital mortality in patients with extensive burns

Changes in Plasma High Mobility Group Box-1 Protein Levels and Its Relationship with Sepsis in Severely Burned Patients

Study on the Relationship Between the Human Leucocyte Antigen-Dr Expression on CD14~+ Monocytes and Sepsis

Level Of Decoy Receptor 3 For Monitoring Clinical Progression Of Severe Burn Patients

Low HLA-DR Expression on CD14+ Monocytes of Burn Victims with Sepsis, and the Effect of Carbachol in Vitro.

Clinical Significance of Changes in Quantitative Expression of Human Leukocyte Antigen DR in Severely Burned Patients

Unremitting pro‐inflammatory T‐cell phenotypes, and macrophage activity, following paediatric burn injury